﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2023v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-11-12T14:28:15-05:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>262669494</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>DAVIES GOLDSTEIN &amp; ASSOCIATES CPA'S</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>PO BOX 156</AddressLine1Txt>
        <CityNm>MATTHEWS</CityNm>
        <StateAbbreviationCd>NC</StateAbbreviationCd>
        <ZIPCd>28106</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>200751232</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>DUP 15Q ALLIANCE</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>DUP1</BusinessNameControlTxt>
      <PhoneNum>8553871572</PhoneNum>
      <USAddress>
        <AddressLine1Txt>250 N TRADE ST STE 205 PMB 155</AddressLine1Txt>
        <CityNm>MATTHEWS</CityNm>
        <StateAbbreviationCd>NC</StateAbbreviationCd>
        <ZIPCd>28105</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>CARRIE HOWELL</PersonNm>
      <PersonTitleTxt>EXECUTIVE DIRECTOR</PersonTitleTxt>
      <PhoneNum>8553871572</PhoneNum>
      <SignatureDt>2024-10-16</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>false</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>JEFFREY I GOLDSTEIN</PreparerPersonNm>
      <PTIN>P00534322</PTIN>
      <PhoneNum>7046840555</PhoneNum>
      <PreparationDt>2024-10-28</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2024-10-15 13:58:12Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="7">
    <IRS990 documentId="RetDoc2" referenceDocumentId="RetDoc6">
      <PrincipalOfficerNm>LISA FEEHERY</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>250 N TRADE ST STE 250 PMB 155</AddressLine1Txt>
        <CityNm>MATTHEWS</CityNm>
        <StateAbbreviationCd>NC</StateAbbreviationCd>
        <ZIPCd>28105</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>931965</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.DUP15Q.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>2004</FormationYr>
      <LegalDomicileStateCd>WI</LegalDomicileStateCd>
      <ActivityOrMissionDesc>WE PROVIDE EDUCATION, RESOURCES, AND SUPPORT TO FAMILIES AND PATIENTS AFFECTED BY DUP15Q SYNDROME, WHILE FIGHTING FOR ADVANCES IN CLINICAL CARE, TREATMENTS, AND SCIENTIFIC RESEARCH.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>9</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>9</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>7</TotalEmployeeCnt>
      <TotalVolunteersCnt>10</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>454102</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>545602</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>15600</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>288671</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>9253</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>8695</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>76194</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>79659</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>555149</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>922627</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>139301</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>247151</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>312361</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>306973</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>51399</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>96392</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>358687</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>548054</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>912811</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>7095</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>9816</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>603477</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>668536</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>80073</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>101183</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>523404</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>567353</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>DUP15Q ALLIANCE EMPOWERS INDIVIDUALS LIVING WITH DUP15Q SYNDROME AND OTHER RELATED RARE DISEASES TO REACH THEIR FULL POTENTIAL BY ADVANCING BREAKTHROUGH RESEARCH AND LIFE-CHANGING THERAPEUTIC TREATMENTS, SUPPORTING FAMILIES AFFECTED BY DUP15Q, AND PROMOTING ADVOCACY. WE ENVISION A WORLD WHERE FAMILIES, CLINICIANS, AND ADVOCATES ENABLE INDIVIDUALS WITH DUP15Q TO LIVE FULL AND PRODUCTIVE LIVES. WE SERVE AS THE LEADER IN RESEARCH, ADVOCACY, AND CLINICAL STANDARDS OF CARE FOR DUP15Q SYNDROME, AND ARE OFTEN THE FIRST POINT OF CONTACT FOR FAMILIES SEARCHING FOR INFORMATION AND RESOURCES REGARDING THEIR CHILD'S DIAGNOSIS.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>247151</ExpenseAmt>
      <GrantAmt>247151</GrantAmt>
      <Desc>PROGRAM: SCIENTIFIC AND CLINICAL INITIATIVES THE DUP15Q ALLIANCE STANDS AT THE FOREFRONT OF COLLABORATIVE EFFORTS WITH STAKEHOLDERS IN ACADEMIC, CLINICAL, AND PHARMACEUTICAL SPACES. IN 2023-24, WE CO-FUNDED A GRANT OF 100,000 WITH CURE EPILEPSY ON A PROJECT AIMING TO DEVELOP A NEW REPRESENTATIVE DUP15Q MOUSE MODEL WITH VARYING LEVELS OF UBA3E (GENE), A VALUABLE TOOL FOR STUDYING THE SYNDROME AND TESTING POTENTIAL THERAPIES. WE ORCHESTRATED A LONGITUDINAL RESEARCH PROJECT DURING OUR 2023 FAMILY CONFERENCE USING FOLLOW-UP DATA COLLECTION AND BIOLOGICAL SAMPLES IN AN ONGOING STUDY OF DUP15Q CHANGES OVER TIME. WE PROVIDED AN ADDITIONAL 38,500 TO THE NEWBORN SCREENING PROJECT, WHICH AIMS TO ADD MULTIPLE CHROMOSOME-15 CONDITIONS TO EARLY CHECK, A SCREEN FOR A VARIETY OF CONDITIONS AT BIRTH. WITH UPENN MEDICINE ORPHAN DISEASE CENTER, WE RAISED NEARLY 50,000 FOR A PROJECT FOCUSED ON UNDERSTANDING THE MOLECULAR PATHWAYS INVOLVED IN NERVOUS SYSTEM DEVELOPMENT AND FUNCTION IN MICE, PARTICULARLY IN THE CONTEXT OF AUTISM SPECTRUM DISORDERS, PROVIDING VALUABLE INFORMATION THAT CAN HELP DESIGN THERAPEUTIC STRATEGIES. THIS YEAR WE ALSO PROVIDED OVER 106,000 FOR THE GROWING LADDER LEARNING NETWORK, WHICH HOSTS A GLOBAL NETWORK OF PATIENT DATA, CONNECTS PROVIDERS TO SHARE VITAL INFORMATION, AND CONNECTS PHARMACEUTICAL PROFESSIONALS WITH LOCATIONS TO HOST CLINICAL TRIALS, WITH THE BENEFIT OF HAVING PATIENTS IN PLACE WHEN TRIALS BECOME AVAILABLE. CURRENTLY, THE 16 US AND 2 INTERNATIONAL DUP15Q CLINICS IN THE NETWORK CONNECT FAMILIES WITH HIGHLY SPECIALIZED MEDICAL PROVIDERS IN A VARIETY OF FIELDS WHO HAVE EXTENSIVE EXPERIENCE TREATING THIS RARE DISORDER. THIS COLLABORATION WITH THE ANGELMAN SYNDROME FOUNDATION ALLOWS US TO EXPAND OUR CLINICAL FOOTPRINT, IMPROVE ACCESS TO CARE, AND BRING TOGETHER A LARGER GROUP OF MEDICAL AND RESEARCH PROFESSIONALS AROUND THE WORLD.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>283528</ExpenseAmt>
        <RevenueAmt>288671</RevenueAmt>
        <Desc>CONFERENCE AND SCIENCE SYMPOSIUM: THIS YEAR WE HOSTED NEARLY 600 PATIENTS, FAMILY MEMBERS, CAREGIVERS, AND PROFESSIONALS FROM AROUND THE WORLD AT THE 12TH INTERNATIONAL FAMILY CONFERENCE AND SCIENCE SYMPOSIUM DURING A WEEK IN JULY, WHERE ATTENDEES FROM 42 STATES AND 13 COUNTRIES MADE NEW PERSONAL AND PROFESSIONAL CONNECTIONS, MET ONE-ON-ONE WITH CLINICIANS AND/OR GENETIC COUNSELORS, AND ATTENDED SESSIONS ON TOPICS SUCH AS GENETICS, CLINICAL TRIALS, BEHAVIORAL HEALTH, SEIZURES, GI ISSUES, AND MUCH MORE. SEVERAL POPULAR BREAKOUT SESSIONS WERE OFFERED, INCLUDING AGE- AND RELATIONSHIP- SPECIFIC SUPPORT GROUPS AND ROUND-TABLE DISCUSSIONS WITH RESEARCHERS. 102 INDIVIDUALS WITH DUP15Q SYNDROME ATTENDED AT NO COST AND HAD THE OPPORTUNITY TO EXPERIENCE OUR WELCOME PARADE, PARTICIPATE IN ACTIVITIES WITH AN OCCUPATIONAL THERAPIST, AND VISIT WITH FRIENDS IN OUR THEMED STAFFED CARE ROOMS AND AT THE BIRTHDAY BASH. OUR SCIENCE SYMPOSIUM HOSTED 113 RESEARCH AND CLINICAL PROFESSIONALS FOR 32 SPEAKER SESSIONS WITH AN ADDITIONAL 12 ABSTRACTS PRESENTED. WE PROVIDED OVER 70,000 IN COMPED REGISTRATION FEES, HOTEL NIGHTS, AND TRAVEL ASSISTANCE VIA SCHOLARSHIPS AND EARNED REWARDS, AND ADDITIONALLY, THE ALLIANCE COVERED OVER 117,000 IN DIRECT CONFERENCE COSTS ABOVE THOSE COVERED BY REGISTRATION AND SPONSORSHIP REVENUE.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>249386</ExpenseAmt>
        <Desc>EDUCATION AND OUTREACH PROGRAMS: DUP15Q ALLIANCE PROVIDES PERSONAL CONNECTIONS, SUPPORT, COMMUNITY AWARENESS, AND EDUCATION TO FAMILIES AND CAREGIVERS OF THOSE AFFECTED BY DUP15Q SYNDROME. IN 2023 WE LAUNCHED A SEARCHABLE RESOURCE NAVIGATOR TO GUIDE FAMILIES TO NON-PROFIT ASSISTANCE, COMMUNITY SUPPORT, AND FUNDING SOURCES; WE PROVIDED 157 LICENSED CLINICAL PROFESSIONAL COUNSELOR SESSIONS AT NO COST TO FAMILIES IN CRISIS; OUR NEW FAMILY INTAKE MANAGER MENTORED 81 NEW DUP15Q ALLIANCE FAMILIES AND PROVIDED GUIDANCE TO NAVIGATE THEIR NEW DIAGNOSIS (MANY FAMILIES FIND IT HELPFUL TO TALK TO SOMEONE WHO CAN ANSWER THEIR QUESTIONS FIRSTHAND); WE LAUNCHED AN INTERACTIVE GUIDE FOR NEWLY DIAGNOSED FAMILIES AND AN ON-DEMAND EDUCATION SECTION ON OUR WEBSITE, TO ASSIST CAREGIVERS IN GETTING THE CRITICAL INFORMATION THEY NEED IN THE DAYS AFTER RECEIVING A DIAGNOSIS OF DUP15Q SYNDROME; WE NOW HAVE 16 COMMUNITY MEMBERS THAT COMPLETED PEER- SUPPORT TRAINING WHO CAN REACH OUT TO FAMILIES IN CRISIS AND/OR MODERATE A VARIETY OF RECURRING SUPPORT GROUPS; 27 WRAPPED IN LOVE BLANKETS WERE SENT TO FAMILIES DURING A HOSPITAL STAY; 12 COMPASSION EXPERIENCE KITS WERE SENT TO TEACH SCHOOL CHILDREN ABOUT DUP15Q SYNDROME; WE BEGAN DEVELOPMENT OF A TRANSITION TO ADULTHOOD ROAD MAP WITH RESOURCES, EDUCATION, AND TIPS FOR CAREGIVERS; AND WE PROVIDED GRANTS AND STAFF ASSISTANCE FOR 5 REGIONAL GATHERINGS OF FAMILIES AND CAREGIVERS.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>780065</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc7">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc3">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc3">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc3">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc3">false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="RetDoc3">false</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc3">false</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc3">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc3">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc3">false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc3">false</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc3">false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc3">true</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc3">false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="RetDoc4">false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="RetDoc4">true</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="RetDoc4">false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc5">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc5">false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>2</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>7</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>true</NondeductibleContributionsInd>
      <NondeductibleContriDisclInd>true</NondeductibleContriDisclInd>
      <QuidProQuoContributionsInd>true</QuidProQuoContributionsInd>
      <QuidProQuoContriDisclInd>true</QuidProQuoContriDisclInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <Form8899Filedind>false</Form8899Filedind>
      <Form1098CFiledInd>false</Form1098CFiledInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>9</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>9</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>false</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>CARRIE HOWELL</PersonNm>
        <PhoneNum>9197024138</PhoneNum>
        <USAddress>
          <AddressLine1Txt>236 PRICE ST</AddressLine1Txt>
          <AddressLine2Txt>APT 207</AddressLine2Txt>
          <CityNm>WAXHAW</CityNm>
          <StateAbbreviationCd>NC</StateAbbreviationCd>
          <ZIPCd>28173</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <NoListedPersonsCompensatedInd>X</NoListedPersonsCompensatedInd>
      <Form990PartVIISectionAGrp>
        <PersonNm>CARRIE HOWELL</PersonNm>
        <TitleTxt>EXECUTIVE DI</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>105000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SOPHIA CACCIATORE</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LISA FEEHERY</PersonNm>
        <TitleTxt>CO-CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>10.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOE IVAN</PersonNm>
        <TitleTxt>SECRETARY/TR</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANNE KARCH</PersonNm>
        <TitleTxt>CO-CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>10.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ELINA MARCHENKO</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MIKE PORATH</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SAM QUIGLEY</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SARAH THACKER</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JACQUELINE VANDERHOOF</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>105000</TotalReportableCompFromOrgAmt>
      <IndivRcvdGreaterThan100KCnt>1</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <AllOtherContributionsAmt>545602</AllOtherContributionsAmt>
      <NoncashContributionsAmt>3864</NoncashContributionsAmt>
      <TotalContributionsAmt>545602</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>CONFERENCE REVENUE</Desc>
        <TotalRevenueColumnAmt>288671</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>288671</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>288671</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>8695</TotalRevenueColumnAmt>
        <ExclusionAmt>8695</ExclusionAmt>
      </InvestmentIncomeGrp>
      <FundraisingGrossIncomeAmt>88007</FundraisingGrossIncomeAmt>
      <FundraisingDirectExpensesAmt>9338</FundraisingDirectExpensesAmt>
      <NetIncmFromFundraisingEvtGrp>
        <TotalRevenueColumnAmt>78669</TotalRevenueColumnAmt>
      </NetIncmFromFundraisingEvtGrp>
      <OtherRevenueMiscGrp>
        <Desc>OTHER INCOME</Desc>
        <TotalRevenueColumnAmt>990</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>990</RelatedOrExemptFuncIncomeAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>990</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>922627</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>289661</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>8695</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>247151</TotalAmt>
        <ProgramServicesAmt>247151</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>284550</TotalAmt>
        <ProgramServicesAmt>216415</ProgramServicesAmt>
        <ManagementAndGeneralAmt>50964</ManagementAndGeneralAmt>
        <FundraisingAmt>17171</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PayrollTaxesGrp>
        <TotalAmt>22423</TotalAmt>
        <ProgramServicesAmt>17042</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4036</ManagementAndGeneralAmt>
        <FundraisingAmt>1345</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>6943</TotalAmt>
        <ManagementAndGeneralAmt>6943</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>7916</TotalAmt>
        <FundraisingAmt>7916</FundraisingAmt>
      </OfficeExpensesGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>243092</TotalAmt>
        <ProgramServicesAmt>243092</ProgramServicesAmt>
      </ConferencesMeetingsGrp>
      <OtherExpensesGrp>
        <Desc>MISCELLANEOUS EXPENSES</Desc>
        <TotalAmt>53950</TotalAmt>
        <ProgramServicesAmt>15929</ProgramServicesAmt>
        <ManagementAndGeneralAmt>13054</ManagementAndGeneralAmt>
        <FundraisingAmt>24967</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>SCIENCE SYMPOSIUM</Desc>
        <TotalAmt>40436</TotalAmt>
        <ProgramServicesAmt>40436</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>RESEARCH</Desc>
        <TotalAmt>6350</TotalAmt>
        <ManagementAndGeneralAmt>6350</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>912811</TotalAmt>
        <ProgramServicesAmt>780065</ProgramServicesAmt>
        <ManagementAndGeneralAmt>81347</ManagementAndGeneralAmt>
        <FundraisingAmt>51399</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>224952</BOYAmt>
        <EOYAmt>226183</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>293979</BOYAmt>
        <EOYAmt>321318</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <AccountsReceivableGrp>
        <BOYAmt>67497</BOYAmt>
        <EOYAmt>106149</EOYAmt>
      </AccountsReceivableGrp>
      <InventoriesForSaleOrUseGrp>
        <BOYAmt>2859</BOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>14190</BOYAmt>
        <EOYAmt>14886</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <TotalAssetsGrp>
        <BOYAmt>603477</BOYAmt>
        <EOYAmt>668536</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>26993</BOYAmt>
        <EOYAmt>62068</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <EOYAmt>24040</EOYAmt>
      </GrantsPayableGrp>
      <DeferredRevenueGrp>
        <BOYAmt>53080</BOYAmt>
        <EOYAmt>15075</EOYAmt>
      </DeferredRevenueGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>80073</BOYAmt>
        <EOYAmt>101183</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>523404</BOYAmt>
        <EOYAmt>567096</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <EOYAmt>257</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>523404</BOYAmt>
        <EOYAmt>567353</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>603477</BOYAmt>
        <EOYAmt>668536</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>9816</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>34133</NetUnrlzdGainsLossesInvstAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc7">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GiftsGrantsContrisRcvd509Grp>
        <CurrentTaxYearMinus4YearsAmt>515718</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>483391</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>569701</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>454102</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>545602</CurrentTaxYearAmt>
        <TotalAmt>2568514</TotalAmt>
      </GiftsGrantsContrisRcvd509Grp>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearMinus2YearsAmt>158662</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>104145</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>377668</CurrentTaxYearAmt>
        <TotalAmt>640475</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <GrossReceiptsNonUnrltBusGrp>
        <CurrentTaxYearMinus4YearsAmt>10710</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>24057</CurrentTaxYearMinus3YearsAmt>
        <TotalAmt>34767</TotalAmt>
      </GrossReceiptsNonUnrltBusGrp>
      <Total509Grp>
        <CurrentTaxYearMinus4YearsAmt>526428</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>507448</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>728363</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>558247</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>923270</CurrentTaxYearAmt>
        <TotalAmt>3243756</TotalAmt>
      </Total509Grp>
      <PublicSupportTotal509Amt>3243756</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearMinus4YearsAmt>13430</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>11665</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>12714</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>9253</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>8695</CurrentTaxYearAmt>
        <TotalAmt>55757</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearMinus4YearsAmt>13430</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>11665</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>12714</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>9253</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>8695</CurrentTaxYearAmt>
        <TotalAmt>55757</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus4YearsAmt>539858</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>519113</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>741077</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>567500</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>931965</CurrentTaxYearAmt>
        <TotalAmt>3299513</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>0.98310</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.98150</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.02000</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.02000</InvestmentIncomePYPct>
      <ThirtyThrPctSuprtTestsCY509Ind>X</ThirtyThrPctSuprtTestsCY509Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc3">
      <TotalRevEtcAuditedFinclStmtAmt>956760</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>34133</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>34133</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>922627</RevenueSubtotalAmt>
      <TotalRevenuePerForm990Amt>922627</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>912811</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesSubtotalAmt>912811</ExpensesSubtotalAmt>
      <TotalExpensesPerForm990Amt>912811</TotalExpensesPerForm990Amt>
    </IRS990ScheduleD>
    <IRS990ScheduleG documentId="RetDoc4">
      <FundraisingEventInformationGrp>
        <Event1Nm>VARIOUS EVENTS</Event1Nm>
        <GrossReceiptsEvent1Amt>84090</GrossReceiptsEvent1Amt>
        <GrossRevenueEvent1Amt>84090</GrossRevenueEvent1Amt>
        <OtherDirectExpensesEvent1Amt>9338</OtherDirectExpensesEvent1Amt>
        <GrossReceiptsTotalAmt>84090</GrossReceiptsTotalAmt>
        <GrossRevenueTotalEventsAmt>84090</GrossRevenueTotalEventsAmt>
        <OthDirectExpnssTotalEventsAmt>9338</OthDirectExpnssTotalEventsAmt>
        <DirectExpenseSummaryEventsAmt>9338</DirectExpenseSummaryEventsAmt>
        <NetIncomeSummaryAmt>74752</NetIncomeSummaryAmt>
      </FundraisingEventInformationGrp>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="RetDoc5">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>FOUNDATION FOR ANGELMAN SYNDROME</BusinessNameLine1Txt>
          <BusinessNameLine2Txt>THERAPEUTICS</BusinessNameLine2Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>75 EXECUTIVE DRIVE STE 327</AddressLine1Txt>
          <CityNm>AURORA</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60504</ZIPCd>
        </USAddress>
        <RecipientEIN>593092842</RecipientEIN>
        <IRCSectionDesc>501C3</IRCSectionDesc>
        <CashGrantAmt>38500</CashGrantAmt>
        <PurposeOfGrantTxt>NEWBORN SCREENING</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>CURE EPILEPSY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>420 N WABASH AVE STE 650</AddressLine1Txt>
          <CityNm>CHICAGO</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60611</ZIPCd>
        </USAddress>
        <RecipientEIN>364253176</RecipientEIN>
        <IRCSectionDesc>501C3</IRCSectionDesc>
        <CashGrantAmt>24040</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>VARIOUS</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <CashGrantAmt>184611</CashGrantAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE I, PAGE 1, PART I, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>THE DUP15 ALLIANCE REQUIRES ANNUAL FINANCIAL AND SCIENTIFIC PROGRESS REPORTING FROM ALL INVESTIGATORS AND SIGNED BY THE GRANTEE INSTITUTION.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleO documentId="RetDoc6">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 - ORGANIZATION'S MISSION</FormAndLineReferenceDesc>
        <ExplanationTxt>DUP15Q ALLIANCE EMPOWERS INDIVIDUALS LIVING WITH DUP15Q SYNDROME AND OTHER RELATED RARE DISEASES TO REACH THEIR FULL POTENTIAL BY ADVANCING BREAKTHROUGH RESEARCH AND LIFE-CHANGING THERAPEUTIC TREATMENTS, SUPPORTING FAMILIES AFFECTED BY DUP15Q, AND PROMOTING ADVOCACY. WE ENVISION A WORLD WHERE FAMILIES, CLINICIANS, AND ADVOCATES ENABLE INDIVIDUALS WITH DUP15Q TO LIVE FULL AND PRODUCTIVE LIVES. WE SERVE AS THE LEADER IN RESEARCH, ADVOCACY, AND CLINICAL STANDARDS OF CARE FOR DUP15Q SYNDROME, AND ARE OFTEN THE FIRST POINT OF CONTACT FOR FAMILIES SEARCHING FOR INFORMATION AND RESOURCES REGARDING THEIR CHILD'S DIAGNOSIS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4A</FormAndLineReferenceDesc>
        <ExplanationTxt>PROGRAM: SCIENTIFIC AND CLINICAL INITIATIVES THE DUP15Q ALLIANCE STANDS AT THE FOREFRONT OF COLLABORATIVE EFFORTS WITH STAKEHOLDERS IN ACADEMIC, CLINICAL, AND PHARMACEUTICAL SPACES. IN 2023-24, WE CO-FUNDED A GRANT OF 100,000 WITH CURE EPILEPSY ON A PROJECT AIMING TO DEVELOP A NEW REPRESENTATIVE DUP15Q MOUSE MODEL WITH VARYING LEVELS OF UBA3E (GENE), A VALUABLE TOOL FOR STUDYING THE SYNDROME AND TESTING POTENTIAL THERAPIES. WE ORCHESTRATED A LONGITUDINAL RESEARCH PROJECT DURING OUR 2023 FAMILY CONFERENCE USING FOLLOW-UP DATA COLLECTION AND BIOLOGICAL SAMPLES IN AN ONGOING STUDY OF DUP15Q CHANGES OVER TIME. WE PROVIDED AN ADDITIONAL 38,500 TO THE NEWBORN SCREENING PROJECT, WHICH AIMS TO ADD MULTIPLE CHROMOSOME-15 CONDITIONS TO EARLY CHECK, A SCREEN FOR A VARIETY OF CONDITIONS AT BIRTH. WITH UPENN MEDICINE ORPHAN DISEASE CENTER, WE RAISED NEARLY 50,000 FOR A PROJECT FOCUSED ON UNDERSTANDING THE MOLECULAR PATHWAYS INVOLVED IN NERVOUS SYSTEM DEVELOPMENT AND FUNCTION IN MICE, PARTICULARLY IN THE CONTEXT OF AUTISM SPECTRUM DISORDERS, PROVIDING VALUABLE INFORMATION THAT CAN HELP DESIGN THERAPEUTIC STRATEGIES. THIS YEAR WE ALSO PROVIDED OVER 106,000 FOR THE GROWING LADDER LEARNING NETWORK, WHICH HOSTS A GLOBAL NETWORK OF PATIENT DATA, CONNECTS PROVIDERS TO SHARE VITAL INFORMATION, AND CONNECTS PHARMACEUTICAL PROFESSIONALS WITH LOCATIONS TO HOST CLINICAL TRIALS, WITH THE BENEFIT OF HAVING PATIENTS IN PLACE WHEN TRIALS BECOME AVAILABLE. CURRENTLY, THE 16 US AND 2 INTERNATIONAL DUP15Q CLINICS IN THE NETWORK CONNECT FAMILIES WITH HIGHLY SPECIALIZED MEDICAL PROVIDERS IN A VARIETY OF FIELDS WHO HAVE EXTENSIVE EXPERIENCE TREATING THIS RARE DISORDER. THIS COLLABORATION WITH THE ANGELMAN SYNDROME FOUNDATION ALLOWS US TO EXPAND OUR CLINICAL FOOTPRINT, IMPROVE ACCESS TO CARE, AND BRING TOGETHER A LARGER GROUP OF MEDICAL AND RESEARCH PROFESSIONALS AROUND THE WORLD.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4B</FormAndLineReferenceDesc>
        <ExplanationTxt>CONFERENCE AND SCIENCE SYMPOSIUM: THIS YEAR WE HOSTED NEARLY 600 PATIENTS, FAMILY MEMBERS, CAREGIVERS, AND PROFESSIONALS FROM AROUND THE WORLD AT THE 12TH INTERNATIONAL FAMILY CONFERENCE AND SCIENCE SYMPOSIUM DURING A WEEK IN JULY, WHERE ATTENDEES FROM 42 STATES AND 13 COUNTRIES MADE NEW PERSONAL AND PROFESSIONAL CONNECTIONS, MET ONE-ON-ONE WITH CLINICIANS AND/OR GENETIC COUNSELORS, AND ATTENDED SESSIONS ON TOPICS SUCH AS GENETICS, CLINICAL TRIALS, BEHAVIORAL HEALTH, SEIZURES, GI ISSUES, AND MUCH MORE. SEVERAL POPULAR BREAKOUT SESSIONS WERE OFFERED, INCLUDING AGE- AND RELATIONSHIP- SPECIFIC SUPPORT GROUPS AND ROUND-TABLE DISCUSSIONS WITH RESEARCHERS. 102 INDIVIDUALS WITH DUP15Q SYNDROME ATTENDED AT NO COST AND HAD THE OPPORTUNITY TO EXPERIENCE OUR WELCOME PARADE, PARTICIPATE IN ACTIVITIES WITH AN OCCUPATIONAL THERAPIST, AND VISIT WITH FRIENDS IN OUR THEMED STAFFED CARE ROOMS AND AT THE BIRTHDAY BASH. OUR SCIENCE SYMPOSIUM HOSTED 113 RESEARCH AND CLINICAL PROFESSIONALS FOR 32 SPEAKER SESSIONS WITH AN ADDITIONAL 12 ABSTRACTS PRESENTED. WE PROVIDED OVER 70,000 IN COMPED REGISTRATION FEES, HOTEL NIGHTS, AND TRAVEL ASSISTANCE VIA SCHOLARSHIPS AND EARNED REWARDS, AND ADDITIONALLY, THE ALLIANCE COVERED OVER 117,000 IN DIRECT CONFERENCE COSTS ABOVE THOSE COVERED BY REGISTRATION AND SPONSORSHIP REVENUE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4C</FormAndLineReferenceDesc>
        <ExplanationTxt>EDUCATION AND OUTREACH PROGRAMS: DUP15Q ALLIANCE PROVIDES PERSONAL CONNECTIONS, SUPPORT, COMMUNITY AWARENESS, AND EDUCATION TO FAMILIES AND CAREGIVERS OF THOSE AFFECTED BY DUP15Q SYNDROME. IN 2023 WE LAUNCHED A SEARCHABLE RESOURCE NAVIGATOR TO GUIDE FAMILIES TO NON-PROFIT ASSISTANCE, COMMUNITY SUPPORT, AND FUNDING SOURCES; WE PROVIDED 157 LICENSED CLINICAL PROFESSIONAL COUNSELOR SESSIONS AT NO COST TO FAMILIES IN CRISIS; OUR NEW FAMILY INTAKE MANAGER MENTORED 81 NEW DUP15Q ALLIANCE FAMILIES AND PROVIDED GUIDANCE TO NAVIGATE THEIR NEW DIAGNOSIS (MANY FAMILIES FIND IT HELPFUL TO TALK TO SOMEONE WHO CAN ANSWER THEIR QUESTIONS FIRSTHAND); WE LAUNCHED AN INTERACTIVE GUIDE FOR NEWLY DIAGNOSED FAMILIES AND AN ON-DEMAND EDUCATION SECTION ON OUR WEBSITE, TO ASSIST CAREGIVERS IN GETTING THE CRITICAL INFORMATION THEY NEED IN THE DAYS AFTER RECEIVING A DIAGNOSIS OF DUP15Q SYNDROME; WE NOW HAVE 16 COMMUNITY MEMBERS THAT COMPLETED PEER- SUPPORT TRAINING WHO CAN REACH OUT TO FAMILIES IN CRISIS AND/OR MODERATE A VARIETY OF RECURRING SUPPORT GROUPS; 27 WRAPPED IN LOVE BLANKETS WERE SENT TO FAMILIES DURING A HOSPITAL STAY; 12 COMPASSION EXPERIENCE KITS WERE SENT TO TEACH SCHOOL CHILDREN ABOUT DUP15Q SYNDROME; WE BEGAN DEVELOPMENT OF A TRANSITION TO ADULTHOOD ROAD MAP WITH RESOURCES, EDUCATION, AND TIPS FOR CAREGIVERS; AND WE PROVIDED GRANTS AND STAFF ASSISTANCE FOR 5 REGIONAL GATHERINGS OF FAMILIES AND CAREGIVERS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>A COMPLETE COPY OF THE FORM 990 IS PROVIDED TO BOARD MEMBERS FOR REVIEW BEFORE FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION HAS A WRITTEN CONFLICT OF INTEREST POLICY. THE DIRECTOR AND ALL OFFICERS ARE REQUIRED TO DISCLOSE ANNUALLY ANY INTERESTS THAT COULD GIVE RISE TO CONFLICTS. THE ORGANIZATION REGULARLY AND CONSISTENTLY MONITORS AND ENFORCES COMPLIANCE WITH THE POLICY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION OFFERS ALL OF ITS INFORMATION FOR PUBLIC INSPECTION UPON REQUEST. THE ORGANIZATION WILL REPORT ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ON THEIR WEBPAGE UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>